Skip to main content
Otezla 20 mg/1 tablet, film coated by Amgen, Inc
Otezla, 20 mg/1, tablet, film coated Drug class: Phosphodiesterase 4 Inhibitor. Available on prescription only. Listed by Amgen, Inc.
Prescription only

Otezla

apremilast

Listed by Amgen, Inc

Strength
20 mg/1
Form
Tablet, Film Coated
Route
Oral
Class
Phosphodiesterase 4 Inhibitor

What it contains

  • Apremilast 20 mg/1

FDA record

Dosage form Tablet, Film Coated
Route Oral
Drug class Phosphodiesterase 4 Inhibitor
Approval route NDA — original brand approval
NDC code 55513-497
FDA application NDA205437
RxNorm concept 1492732
Package sizes listed 1
Marketed since April 2024

Other products containing Apremilast

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

Otezla

apremilast

Strength
30 mg/1
Form
Tablet, Film Coated
Class
Phosphodiesterase 4 Inhibitor
Rx only

Amgen, Inc

$51.84 We supply Aprezo 30 mg (1 pack / 30 tabs) View product

Otezla

apremilast

Strength
75 mg/1
Form
Tablet, Film Coated
Class
Phosphodiesterase 4 Inhibitor
Rx only

Amgen, Inc

$51.84 We supply Aprezo 30 mg (1 pack / 30 tabs) (different strength or form) View product

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.